143 related articles for article (PubMed ID: 12164381)
1. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.
Zara GP; Cavalli R; Bargoni A; Fundarò A; Vighetto D; Gasco MR
J Drug Target; 2002 Jun; 10(4):327-35. PubMed ID: 12164381
[TBL] [Abstract][Full Text] [Related]
2. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
Fundarò A; Cavalli R; Bargoni A; Vighetto D; Zara GP; Gasco MR
Pharmacol Res; 2000 Oct; 42(4):337-43. PubMed ID: 10987994
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
Zara GP; Cavalli R; Fundarò A; Bargoni A; Caputo O; Gasco MR
Pharmacol Res; 1999 Sep; 40(3):281-6. PubMed ID: 10479474
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit.
Cusack BJ; Young SP; Driskell J; Olson RD
Cancer Chemother Pharmacol; 1993; 32(1):53-8. PubMed ID: 8462124
[TBL] [Abstract][Full Text] [Related]
5. Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution.
Bargoni A; Cavalli R; Zara GP; Fundarò A; Caputo O; Gasco MR
Pharmacol Res; 2001 May; 43(5):497-502. PubMed ID: 11394943
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration.
Ren J; Zou M; Gao P; Wang Y; Cheng G
Eur J Pharm Biopharm; 2013 Feb; 83(2):141-8. PubMed ID: 23201052
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.
Zara GP; Bargoni A; Cavalli R; Fundarò A; Vighetto D; Gasco MR
J Pharm Sci; 2002 May; 91(5):1324-33. PubMed ID: 11977108
[TBL] [Abstract][Full Text] [Related]
8. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.
Gulyaev AE; Gelperina SE; Skidan IN; Antropov AS; Kivman GY; Kreuter J
Pharm Res; 1999 Oct; 16(10):1564-9. PubMed ID: 10554098
[TBL] [Abstract][Full Text] [Related]
9. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats.
Ambruosi A; Yamamoto H; Kreuter J
J Drug Target; 2005 Dec; 13(10):535-42. PubMed ID: 16390814
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles.
Verdun C; Brasseur F; Vranckx H; Couvreur P; Roland M
Cancer Chemother Pharmacol; 1990; 26(1):13-8. PubMed ID: 2322986
[TBL] [Abstract][Full Text] [Related]
11. Chapter 10 - Solid lipid nanoparticles and microemulsions for drug delivery The CNS.
Gasco MR; Priano L; Zara GP
Prog Brain Res; 2009; 180():181-92. PubMed ID: 20302835
[TBL] [Abstract][Full Text] [Related]
12. Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles and Its Mechanism.
Malik Z; Parveen R; Abass S; Irfan Dar M; Husain SA; Ahmad S
Curr Drug Metab; 2022; 23(10):800-817. PubMed ID: 35430962
[TBL] [Abstract][Full Text] [Related]
13. Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines.
Serpe L; Guido M; Canaparo R; Muntoni E; Cavalli R; Panzanelli P; Della Pepal C; Bargoni A; Mauro A; Gasco MR; Eandi M; Zara GP
J Nanosci Nanotechnol; 2006; 6(9-10):3062-9. PubMed ID: 17048519
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
15. Increased brain uptake of venlafaxine loaded solid lipid nanoparticles by overcoming the efflux function and expression of P-gp.
Zhou Y; Zhang G; Rao Z; Yang Y; Zhou Q; Qin H; Wei Y; Wu X
Arch Pharm Res; 2015 Jul; 38(7):1325-35. PubMed ID: 25567760
[TBL] [Abstract][Full Text] [Related]
16. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles.
Alhareth K; Vauthier C; Gueutin C; Ponchel G; Moussa F
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():128-32. PubMed ID: 22341684
[TBL] [Abstract][Full Text] [Related]
17. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
[TBL] [Abstract][Full Text] [Related]
18. Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticles.
Alhareth K; Vauthier C; Bourasset F; Gueutin C; Ponchel G; Moussa F
Eur J Pharm Biopharm; 2012 Jun; 81(2):453-7. PubMed ID: 22465096
[TBL] [Abstract][Full Text] [Related]
19. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
Zhang C; Wu Y; Dong Y; Xu H; Zhao L
Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
[TBL] [Abstract][Full Text] [Related]
20. Formulation and pharmacokinetic evaluation of tetracycline-loaded solid lipid nanoparticles for subcutaneous injection in mice.
Xu XM; Wang YS; Chen RY; Feng CL; Yao F; Tong SS; Wang L; Yamashita F; Yu JN
Chem Pharm Bull (Tokyo); 2011; 59(2):260-5. PubMed ID: 21297309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
